TerrAscend (TSNDF) Capital Expenditures (2021 - 2026)
TerrAscend's (TSNDF) quarterly Capital Expenditures came in at $865000.0 in Q1 2026, down 63.32% year-on-year from $2.4 million in Q1 2025, and down 49.59% on a QoQ basis from $1.7 million in Q4 2025.
TerrAscend (TSNDF) Capital Expenditures (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Capital Expenditures data on file, last reported at $865000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 63.32% year-over-year to $865000.0 in Q1 2026; TTM through Mar 2026 was $7.1 million, a 10.78% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 25.46% from the prior year.
- Capital Expenditures for Q1 2026 stood at $865000.0, down from $1.7 million in the prior quarter.
- Over the last five years, Capital Expenditures for TSNDF reached as high as $27.5 million in Q4 2022 and fell as low as -$2.0 million in Q2 2023.
- Historically, Capital Expenditures has averaged $3.6 million across 5 years, with a median of $2.2 million in 2025.
- Across the five-year window, Capital Expenditures slumped 115.81% in 2023 and soared 13123.53% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $27.5 million in 2022, then slumped by 85.7% to $3.9 million in 2023, then fell by 29.99% to $2.8 million in 2024, then plunged by 37.71% to $1.7 million in 2025, then tumbled by 49.59% to $865000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $865000.0 in Q1 2026, $1.7 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 865,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 865,000.00 |
| Mar 31, 2026 | 865,000.00 |
| Dec 31, 2025 | 1.72 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Dec 31, 2024 | 2.76 Mn |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |